Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters.

Author/creator United States
Format Electronic
EditionRevised.
Publication[Washington, D.C.] : United States Government Accountability Office, 2013.
Description1 online resource (iii, 40 pages) : illustrations
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo46110
Subjects

Uniform titleMedicaid prescription drugs (2013 December)
Variant title Medicaid prescription drugs : Centers for Medicare & Medicaid Services should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs
Portion of title CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs
General noteTitle from title screen (viewed Feb. 13, 2014).
General note"December 2013."
General note"This report was revised on February 6, 2014 to correct the omission of reprinting written comments from the Department of Health and Human Services (HHS) on a draft report. A copy of the HHS's written comments was inserted in appendix V."
General note"GAO-14-68."
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Technical rpt numberGAO-14-68
GPO item number0546-D (online)
Govt. docs number GA 1.13:GAO-14-68

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available